In addition, it has been shown that thioredoxins have a protective role in several cardiovascular diseases, as such the TrxR/Trx system might be a target for development new clinical therapies in the treatment of cardiovascular pathologies [51,52,53]. The gene discussed is TXN; the disease is cardiovascular disorder.